Profile Picture
Rewards
  • All
  • Chat
  • Images
  • Videos
  • Maps
  • News
  • Shopping
  • More
    • Flights
    • Travel
    • Hotels
    • Real Estate
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business

Trending on Bing

Renegotiates prenup
Beaver born after 400 years
To ban caste discrimination
Wins an Emmy
6 killed in mine collapse
6,000-year-old sandals found
UKR shoots down 30 drones
Nabs $2M in preview
Making NHL history
Migrants risk rape
X losing daily active users
Signs 1-yr contract extension
Primo suspended 4 games
Files for bankruptcy
Staples' ex-exec sentenced
US operations chief resigns
Canceled at ABC
To make NFL return
Sea lion escapes zoo
Giants fire Gabe Kapler
Homeless sue Portland
Red wolf needs help to live
To run as independent?
Ex-ABC reporter sentenced
Faces new civil suit
National parks set to close?
Charges IRS consultant
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
233,000 results
1d
First FDA Approved Drug to Slow Alzheimer’s
Joan was diagnosed with early-stage Alzheimer’s disease. There was nothing doctors could do. But now, a recently FDA-approved ...
朝日新聞社11d
Alzheimer’s drug Leqembi has full FDA approval
Alzheimer’s drug Leqembi has full FDA approval THE ASSOCIATED PRESS July 7, 2023 at 07:30 ... WASHINGTON--U.S. officials granted full approval to a closely watched Alzheimer’s drug on ...
1d
FDA advisers vote against experimental ALS treatment pushed by patients
The panel of Food and Drug Administration experts voted 17-1 that drugmaker Brainstorm’s stem cell-based treatment has not ...
The Courier-Journal9d
Delaying Alzheimer's: Norton begins administering new drug to slow dementia progression
Every two weeks, Pam Jeffries settles into an armchair and waits for an infusion of a groundbreaking treatment for her memory loss. The new drug, which was approved by the FDA earlier this year ...
AOL4d
Experimental treatment pushed by ALS patients gets day before FDA, but agency unconvinced it works
WASHINGTON (AP) — The Food and Drug Administration meets this week to consider approval of an experimental treatment for Lou Gehrig’s disease, the culmination of a yearslong lobbying effort by ...
Afro18d
Why is Medicare rationing Alzheimer’s drugs?
The FDA has recently approved exciting new treatments that can slow the progression of Alzheimer’s disease, a scourge that claims more American lives than breast cancer and prostate cancer combined.
Too Old to Operate
1d
FDA Panel Says No to Experimental ALS Drug
An advisory panel to the U.S. Food and Drug Administration on Wednesday voted resoundingly against recommending a stem ...
Salon16d
Navigating new Alzheimer's drugs can be confusing and expensive. So do they really help patients?
For decades, attempts to treat or slow Alzheimer's disease (AD) — a brain disorder that causes dementia through damage to brain cells and other changes in the brain — have been dispiriting ...
The Washington Post18h
FDA wants to regulate thousands of lab tests that have long skirted oversight
WASHINGTON — The Food and Drug Administration on Friday laid out a proposal to begin regulating laboratory medical tests, a ...
1d
Ticking Time Bombs: 3 New Stocks to Dump Before the Damage Is Done (IPO)
InvestorPlace - Stock Market News, Stock Advice & Trading Tips The IPO market in 2023 has been anything but hot. After a ...
Scientific American10d
Should You Get a Blood Test For Alzheimer's?
Consumers can now get easy tests for Alzheimer’s. But these tests may not really help patients that much–yet. Josh Fischman: We bring you the latest vital health news: Discoveries that affect ...
WISH-TV
2d
Health Spotlight: First FDA-approved drug to slow Alzheimer’s
More than 6,000,000 Americans are living with Alzheimer's disease – it slowly steals your memories and takes away your mind ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
© 2023 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices